The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases. The study highlights the transformative potential of EZH2 inhibition, paving the way for a new generation of targeted therapies aimed at disrupting tumor growth and overcoming treatment resistance.

The University of Texas at Arlington hosted 530 of the brightest minds from North Texas’ middle and high schools last month for the 74th Fort Worth Regional Science and Engineering Fair. The fair attracted more students than ever, with the number of participants increasing by more than 25% over 2024. Engineering remains a high-demand field, especially in Texas, where the economy and the population continue to grow.